UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (293) 293
science & technology (238) 238
life sciences & biomedicine (221) 221
male (178) 178
naphthyridines - adverse effects (175) 175
naphthyridines - therapeutic use (152) 152
female (151) 151
adult (117) 117
fluoroquinolones (110) 110
naphthyridines - pharmacology (109) 109
pharmacology & pharmacy (103) 103
middle aged (102) 102
animals (99) 99
naphthyridines - administration & dosage (84) 84
aged (83) 83
anti-infective agents - adverse effects (82) 82
anti-infective agents - therapeutic use (58) 58
naphthyridines - pharmacokinetics (56) 56
adolescent (53) 53
treatment outcome (51) 51
double-blind method (50) 50
gemifloxacin (44) 44
infectious diseases (39) 39
fluoroquinolones - adverse effects (38) 38
microbiology (36) 36
anti-bacterial agents - adverse effects (32) 32
administration, oral (31) 31
anti-infective agents - pharmacology (31) 31
mice (31) 31
aged, 80 and over (30) 30
anti-bacterial agents - therapeutic use (30) 30
anti-infective agents - pharmacokinetics (29) 29
enoxacin (28) 28
oncology (28) 28
anti-infective agents - administration & dosage (27) 27
bacterial infections - drug therapy (27) 27
dose-response relationship, drug (27) 27
drug interactions (27) 27
trovafloxacin (27) 27
fluoroquinolones - therapeutic use (26) 26
rats (25) 25
child (23) 23
clinical trials as topic (23) 23
abridged index medicus (22) 22
community-acquired infections - drug therapy (22) 22
drug therapy (22) 22
cross-over studies (21) 21
general & internal medicine (21) 21
clinical trials (20) 20
medicine, general & internal (20) 20
microbial sensitivity tests (20) 20
pharmacokinetics (20) 20
fluoroquinolone (19) 19
internal medicine (19) 19
naphthyridines - chemistry (19) 19
antibiotics (18) 18
toxicology (18) 18
care and treatment (17) 17
chronic disease (17) 17
drug administration schedule (17) 17
drug therapy, combination (17) 17
fluoroquinolones - administration & dosage (17) 17
research (17) 17
young adult (17) 17
acute disease (16) 16
child, preschool (16) 16
malaria (16) 16
naphthyridines - blood (16) 16
analysis (15) 15
anti-bacterial agents - administration & dosage (15) 15
anti-bacterial agents - pharmacology (15) 15
antimalarials - adverse effects (15) 15
disease models, animal (15) 15
leukemia, myeloid, acute - drug therapy (15) 15
levofloxacin (15) 15
malaria, falciparum - drug therapy (15) 15
pneumonia, bacterial - drug therapy (15) 15
apoptosis - drug effects (14) 14
area under curve (14) 14
bronchitis - drug therapy (14) 14
drug evaluation (14) 14
health aspects (14) 14
immunology (14) 14
multidisciplinary sciences (14) 14
naphthyridines - toxicity (14) 14
pharmacology/toxicology (14) 14
safety (14) 14
science & technology - other topics (14) 14
antimalarials - therapeutic use (13) 13
antineoplastic agents - pharmacology (13) 13
drug combinations (13) 13
medicine & public health (13) 13
naphthyridines (13) 13
pneumonia (13) 13
antimalarials - administration & dosage (12) 12
cardiovascular system & cardiology (12) 12
infant (12) 12
mortality (12) 12
ofloxacin - adverse effects (12) 12
pharmacology (12) 12
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (329) 329
Japanese (17) 17
Chinese (4) 4
German (2) 2
Danish (1) 1
Polish (1) 1
Spanish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical infectious diseases, ISSN 1058-4838, 10/2014, Volume 59, Issue 8, pp. 1083 - 1091
Background. Ceftriaxone is the foundation of currently recommended gonorrhea treatment. There is an urgent need for backup treatment options for patients with... 
Sexually transmitted diseases | Neisseria gonorrhoeae | Cephalosporins | Antimicrobials | Men | Clinical trials | Infections | Gonorrhea | Preventive medicine | ARTICLES AND COMMENTARIES | School enrollment | Gemifloxacin | Gonorrhea treatment | Gentamicin | Azithromycin | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Gastrointestinal Diseases - epidemiology | Naphthyridines - adverse effects | United States | Humans | Middle Aged | Male | Drug-Related Side Effects and Adverse Reactions - pathology | Young Adult | Anti-Bacterial Agents - therapeutic use | Drug Therapy, Combination - adverse effects | Gastrointestinal Diseases - pathology | Adult | Female | Anti-Bacterial Agents - adverse effects | Gentamicins - adverse effects | Gentamicins - therapeutic use | Administration, Oral | Fluoroquinolones - therapeutic use | Treatment Outcome | Injections, Intramuscular | Gonorrhea - drug therapy | Fluoroquinolones - adverse effects | Drug-Related Side Effects and Adverse Reactions - epidemiology | Azithromycin - adverse effects | Neisseria gonorrhoeae - isolation & purification | Drug Therapy, Combination - methods | Azithromycin - therapeutic use | Naphthyridines - therapeutic use | Adolescent | Gastrointestinal Diseases - chemically induced | Care and treatment | Dosage and administration | Risk factors | Antimicrobial agents | Effectiveness | Drug therapy | Drug resistance | Product safety | Index Medicus | gentamicin | azithromycin | and Commentaries | gemifloxacin | gonorrhea treatment
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 09/2015, Volume 314, Issue 9, pp. 884 - 894
... underused because of a high risk of adverse events. OBJECTIVE: To evaluate the safety and efficacy of different oral doses of the nonsteroidal mineralocorticoid receptor antagonist finerenone, given for 90 days to patients with diabetes and high or very high... 
Blood Pressure | Creatinine | Glomerular Filtration Rate | Diabetic Nephropathies | Double-Blind Method | Drug Administration Schedule | Naphthyridines | Administration, Oral | Angiotensin Receptor Antagonists | Humans | Middle Aged | Male | Albuminuria | Incidence | Dose-Response Relationship, Drug | Hyperkalemia | Analysis of Variance | Angiotensin-Converting Enzyme Inhibitors | Least-Squares Analysis | Female | Aged | Diabetes Mellitus, Type 2 | Mineralocorticoid Receptor Antagonists | Potassium | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Naphthyridines - adverse effects | Diabetic Nephropathies - drug therapy | Diabetes Mellitus, Type 2 - ethnology | Glomerular Filtration Rate - drug effects | Diabetic Nephropathies - physiopathology | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Hyperkalemia - epidemiology | Blood Pressure - drug effects | Diabetes Mellitus, Type 2 - complications | Diabetic Nephropathies - urine | Diabetes Mellitus, Type 2 - urine | Diabetic Nephropathies - ethnology | Creatinine - urine | Mineralocorticoid Receptor Antagonists - therapeutic use | Albuminuria - drug therapy | Hyperkalemia - chemically induced | Potassium - blood | Angiotensin Receptor Antagonists - therapeutic use | Naphthyridines - administration & dosage | Proteins | Clinical trials | Side effects | Diabetes | Antagonist drugs | ACE inhibitors | Index Medicus | Abridged Index Medicus
Journal Article
PloS one, ISSN 1932-6203, 01/2011, Volume 6, Issue 1, pp. e14501 - e14501
Journal Article
Journal of diabetes and its complications, ISSN 1056-8727, 04/2017, Volume 31, Issue 4, pp. 758 - 765
.... Results Analysis of the urinary albumin-to-creatinine ratio (UACR) at day 90 relative to baseline indicated a nominally significant effect of finerenone... 
Endocrinology & Metabolism | Type 2 diabetes | Diabetic nephropathy | Albuminuria | Finerenone | MRA | Biomarkers - urine | Follow-Up Studies | Naphthyridines - adverse effects | Humans | Middle Aged | Diabetic Nephropathies - drug therapy | Male | Diabetic Nephropathies - blood | Dose-Response Relationship, Drug | Drug Therapy, Combination - adverse effects | Glomerular Filtration Rate - drug effects | Diabetic Nephropathies - physiopathology | Renal Insufficiency - physiopathology | Female | Renal Insufficiency - complications | Renal Insufficiency - drug therapy | Diabetes Mellitus, Type 2 - complications | Kidney - physiopathology | Diabetic Nephropathies - urine | Mineralocorticoid Receptor Antagonists - administration & dosage | Reproducibility of Results | Kidney - drug effects | Albuminuria - etiology | Double-Blind Method | Japan | Mineralocorticoid Receptor Antagonists - adverse effects | Renal Insufficiency - metabolism | Biomarkers - blood | Albuminuria - prevention & control | Disease Progression | Mineralocorticoid Receptor Antagonists - therapeutic use | Naphthyridines - therapeutic use | Renin-Angiotensin System - drug effects | Aged | Naphthyridines - administration & dosage | Clinical trials | Diabetic nephropathies | Diabetes therapy | Medical research | Albumin | Medicine, Experimental | Drug discovery | Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 04/2012, Volume 366, Issue 14, pp. 1298 - 1309
Journal Article
Journal Article